Aeromonas salmonicida (Furunculosis): Etiology, Pathogenesis, and Control

Introduction

Aeromonas salmonicida is a Gram-negative, non-motile, facultatively anaerobic bacterium that is the primary etiological agent of furunculosis, a systemic and often fatal disease of salmonid and non-salmonid fish species [1, 2]. The disease is characterized by the formation of furuncles (boil-like lesions) in the musculature, although peracute and acute forms without external lesions are common [3]. The pathogen has a broad host range that includes Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), turbot (Scophthalmus maximus), sturgeon (Acipenser baerii), and other freshwater and marine fish [4, 5, 6]. Isolates have also been recovered from non-fish hosts including pigs and cattle, indicating a wider ecological distribution than previously recognized [1, 7]. This article provides a comprehensive review of the taxonomy, virulence mechanisms, pathogenesis, host immune responses, diagnostic approaches, and control strategies for A. salmonicida and furunculosis.

Taxonomy and Subspecies Diversity

Aeromonas salmonicida belongs to the family Aeromonadaceae within the class Gammaproteobacteria [8]. The species is divided into several subspecies, including A. salmonicida subsp. salmonicida (the typical furunculosis agent), A. salmonicida subsp. masoucida, A. salmonicida subsp. achromogenes, and A. salmonicida subsp. oncorhynchi [9, 10]. Subspecies differentiation is based on biochemical profiles, growth characteristics, and genomic content [10]. The typical subspecies (salmonicida) is considered the most virulent and is responsible for classical furunculosis in salmonids [8]. Atypical subspecies, such as A. salmonicida subsp. achromogenes, are associated with chronic or ulcerative disease in a wider range of fish species [6]. Genomic and pangenomic analyses have revealed substantial genetic diversity within the species, with mobile genetic elements and genomic islands contributing to strain-specific virulence and antimicrobial resistance profiles [10, 11].

Etiology and Biophysical Characteristics

A. salmonicida is a non-motile, Gram-negative rod measuring approximately 1.0 to 3.5 micrometers in length and 0.5 to 1.0 micrometer in width [3]. The bacterium is a facultative anaerobe that grows optimally at temperatures between 20 and 25 degrees Celsius, although strain-dependent thermoadaptation has been documented [12]. The organism produces a brown, water-soluble pigment on tryptic soy agar, a key phenotypic feature used in preliminary identification [3]. The cell envelope contains a lipopolysaccharide (LPS) layer, a thin peptidoglycan layer, and an outer membrane that houses various virulence-associated proteins [13]. A. salmonicida produces several extracellular products (ECPs) including proteases, hemolysins, and leukocidins that contribute to tissue damage and immune evasion [14, 15]. The bacterium also secretes outer membrane vesicles (OMVs) that contain GroEL chaperone proteins and other immunomodulatory molecules [13]. These OMVs have been shown to inhibit biofilm formation by competing bacteria such as Pseudomonas fluorescens [14].

Virulence Factors and Pathogenesis

The virulence arsenal of A. salmonicida is multifaceted and includes surface-associated factors, secreted enzymes, and regulatory systems. The A-layer, a paracrystalline surface protein array (S-layer), is a critical virulence determinant that mediates adhesion to host cells and provides protection against complement-mediated lysis [8]. The type III secretion system (T3SS) is a needle-like apparatus that injects effector proteins directly into host cell cytoplasm, disrupting cytoskeletal dynamics and apoptotic pathways [16]. The type VI secretion system (T6SS) is also present in many strains and contributes to interbacterial competition and host cell manipulation [8].

Extracellular enzymes include a 70-kDa serine protease (P1) and a 20-kDa metalloprotease (P2) that degrade host connective tissues and facilitate systemic dissemination [15]. A. salmonicida also produces a GCAT (glycerophospholipid:cholesterol acyltransferase) that acts as a hemolysin and leukocidin [14]. The bacterium produces a melanin-like pigment that has immunomodulatory effects on Atlantic salmon macrophages, altering respiratory burst activity and cytokine expression [17]. Quorum sensing (QS) systems, including the AhyI/AhyR homologs, regulate the expression of virulence factors in a cell-density-dependent manner [18]. Resveratrol has been shown to block QS-mediated virulence phenotypes in A. salmonicida isolated from sturgeon [18].

Cold shock proteins, particularly CspA, play a role in the physiology and virulence of A. salmonicida subsp. salmonicida, enabling the bacterium to adapt to low-temperature environments common in aquaculture settings [19]. Strain-dependent thermoadaptation has been observed, with some strains maintaining virulence at temperatures above 25 degrees Celsius [12]. Mobile genomic islands, such as GEI-FN1A, contribute to the spread of antibiotic resistance genes among A. salmonicida populations [11].

Host Range and Clinical Presentation

A. salmonicida infects a wide range of fish species, including Atlantic salmon, rainbow trout, brown trout (Salmo trutta fario), turbot, sturgeon, grass carp (Ctenopharyngodon idella), and large yellow croaker [4, 5, 20, 21, 22]. The bacterium has also been isolated from mammals, including pigs and cattle, although the clinical significance in these hosts remains under investigation [1, 7]. A case of A. salmonicida peritonitis in a human undergoing peritoneal dialysis has been reported, but this is considered an opportunistic infection in an immunocompromised host [23].

Furunculosis presents in peracute, acute, and chronic forms. Peracute disease causes sudden mortality without premonitory signs [3]. Acute disease is characterized by septicemia, lethargy, anorexia, darkening of the skin, and hemorrhages at the base of fins [3]. Chronic disease is marked by the formation of furuncles, which are necrotic, liquefactive lesions in the epaxial musculature that rupture to the surface [6]. In turbot, chronic aeromoniasis has been associated with epibiotic green algae (Ulva spp.) on the skin [6]. Co-infection with Flavobacterium psychrophilum in rainbow trout results in synergistic increases in mortality and more severe pathophysiological alterations compared to single infections [24].

Pathogenesis and Host Immune Responses

The pathogenesis of furunculosis begins with bacterial adhesion to the gill epithelium or skin, followed by invasion of the underlying tissues and entry into the bloodstream [25]. A. salmonicida infection inhibits mucin production in rainbow trout gills, compromising the mucosal barrier and facilitating bacterial entry [25]. Once in the bloodstream, the bacterium multiplies rapidly, causing a fulminant septicemia [3].

The host immune response to A. salmonicida involves both innate and adaptive components. In Atlantic salmon primary macrophages, dual-seq transcriptomics has revealed that infection induces lysosomal and apoptotic impairments, allowing the bacterium to survive intracellularly [16]. In turbot, liver transcriptome analysis has shown that multiple immune processes and lipid metabolism pathways are involved in the defense response [4]. In brown trout, transcriptome and resequencing studies have identified immune-related genes and molecular markers associated with resistance to A. salmonicida [20]. The septin gene family in rainbow trout is differentially expressed in response to A. salmonicida infection, suggesting a role in cytoskeletal remodeling during the immune response [26].

Probiotic supplementation with Lactiplantibacillus plantarum has been shown to modulate the immune response and improve survival in rainbow trout challenged with A. salmonicida [27]. Similarly, gamma-irradiated Bifidobacterium longum subsp. infantis enhances immune modulation and resistance to furunculosis in rainbow trout [28]. Functional feeds containing immunomodulatory ingredients have been evaluated for their ability to mitigate the effects of A. salmonicida outbreaks [29]. Agaricus bisporus polysaccharides have been shown to alleviate A. salmonicida-induced enteritis in crayfish through modulation of the intestinal microbiota and immune gene expression [30].

Diagnostic Approaches

Diagnosis of furunculosis is based on clinical signs, gross pathology, histopathology, and laboratory confirmation of the causative agent. Standard bacteriological culture involves isolation of the organism from kidney, spleen, or furuncle material on tryptic soy agar or brain heart infusion agar [3]. Colonies are typically small, convex, and produce a brown diffusible pigment after 48 to 72 hours of incubation at 22 degrees Celsius [3].

Biochemical identification is based on the following characteristics: Gram-negative rod, non-motile, oxidase-positive, catalase-positive, and fermentative metabolism of glucose [3]. Molecular diagnostics include PCR targeting the 16S rRNA gene, the aroA gene, or the vapA gene encoding the A-layer protein [8]. High-throughput sequencing approaches, including nanopore genome sequencing, have been used to characterize A. salmonicida strains from diseased sturgeon [5]. Whole-genome sequencing and pangenomic analyses provide detailed insights into virulence gene content, antimicrobial resistance determinants, and phylogenetic relationships [8, 10].

Serological methods, including ELISA and agglutination tests, can detect antibodies against A. salmonicida in fish sera, although these are more commonly used for research purposes than for routine diagnosis [2]. Histopathology reveals necrotic muscle tissue with bacterial aggregates, hemorrhage, and inflammatory cell infiltration [3].

The following table summarizes the key diagnostic methods for A. salmonicida:

Control and Prevention

Control of furunculosis relies on a combination of biosecurity measures, vaccination, antimicrobial therapy, and immunomodulatory feed additives. Vaccination is the most effective long-term strategy for preventing disease in farmed salmonids. Combined vaccines against vibriosis and typical and atypical furunculosis have been developed and shown to be effective in Atlantic salmon [2]. Autogenous vaccines, prepared from inactivated local isolates, are used when commercial vaccines are not available or when specific serotypes are involved [31]. Transcriptomic insights have been used to optimize the cultivation conditions for autogenous vaccine production, ensuring that virulence-associated antigens are expressed during vaccine preparation [31].

Antimicrobial therapy is used for treatment of clinical outbreaks, but the emergence of antimicrobial resistance (AMR) is a growing concern [1, 32]. A. salmonicida isolates from Atlantic salmon have shown variable susceptibility to antibiotics, with some strains exhibiting resistance to multiple drug classes [32]. Genomic characterization of A. salmonicida from pigs has revealed the presence of AMR genes, including those conferring resistance to tetracyclines, beta-lactams, and aminoglycosides [1]. Mobile genomic islands contribute to the horizontal transfer of resistance genes [11]. Synergistic combinations of gentamicin, levofloxacin, and cefotaxime have been evaluated in vitro and in vivo against A. salmonicida, showing enhanced efficacy compared to monotherapy [33].

Phage therapy represents an emerging alternative to antibiotics. Phage TSW001 has been isolated and characterized for its ability to lyse A. salmonicida, and its application on large yellow croaker has shown promise in reducing bacterial loads [22]. Quorum sensing inhibitors, such as resveratrol, offer another avenue for controlling virulence without exerting selective pressure for resistance [18].

The following Mermaid diagram illustrates a decision tree for the management of a furunculosis outbreak:

flowchart TD
    A[Clinical signs of furunculosis], > B{Confirm diagnosis}
    B, > C[Bacterial culture and PCR]
    C, > D{Positive for A. salmonicida?}
    D, >|Yes| E[Assess outbreak severity]
    D, >|No| F[Consider differential diagnoses]
    E, > G{High mortality?}
    G, >|Yes| H[Initiate antimicrobial therapy]
    G, >|No| I[Implement biosecurity measures]
    H, > J[Perform antimicrobial susceptibility testing]
    J, > K[Select appropriate antibiotic]
    K, > L[Monitor treatment response]
    L, > M{Improvement?}
    M, >|Yes| N[Continue treatment and vaccinate survivors]
    M, >|No| O[Re-evaluate diagnosis and susceptibility]
    I, > P[Vaccinate at-risk populations]
    P, > Q[Implement functional feed additives]
    Q, > R[Monitor for recurrence]

Frequently Asked Questions

What is the primary host range of Aeromonas salmonicida?

The primary host range of A. salmonicida includes salmonid fish such as Atlantic salmon, rainbow trout, and brown trout, but the bacterium also infects non-salmonid species including turbot, sturgeon, grass carp, and large yellow croaker [4, 5, 20, 21, 22].

How does A. salmonicida cause disease in fish?

A. salmonicida causes disease through a combination of surface-associated virulence factors (A-layer, T3SS, T6SS), secreted enzymes (proteases, hemolysins, GCAT), and quorum sensing-regulated gene expression that collectively facilitate adhesion, tissue invasion, immune evasion, and systemic dissemination [14, 18, 15, 8, 16].

What are the typical clinical signs of furunculosis?

Typical clinical signs of furunculosis include lethargy, anorexia, darkening of the skin, hemorrhages at fin bases, and the formation of furuncles (necrotic muscle lesions) in chronic cases, while peracute and acute forms present as sudden mortality without external lesions [6, 3].

How is A. salmonicida diagnosed in a laboratory setting?

A. salmonicida is diagnosed by bacterial culture from kidney or spleen tissue, biochemical profiling (Gram-negative, non-motile, oxidase-positive, fermentative), PCR targeting the 16S rRNA, aroA, or vapA genes, and whole-genome sequencing for strain characterization [5, 3, 8].

What control strategies are available for furunculosis?

Control strategies for furunculosis include vaccination with commercial or autogenous vaccines, antimicrobial therapy guided by susceptibility testing, biosecurity measures, phage therapy, quorum sensing inhibitors, and immunomodulatory feed additives [2, 28, 27, 18, 31, 33, 29, 22].

Can A. salmonicida infect mammals?

A. salmonicida has been isolated from pigs and cattle, and a single case of peritonitis in a human undergoing peritoneal dialysis has been reported, but the bacterium is primarily a fish pathogen and mammalian infections are rare and opportunistic [1, 7, 23].

What is the role of quorum sensing in A. salmonicida virulence?

Quorum sensing in A. salmonicida regulates the expression of virulence factors including proteases and hemolysins in a cell-density-dependent manner, and inhibition of QS by compounds such as resveratrol can attenuate virulence without killing the bacterium [18].

Are there effective vaccines against furunculosis?

Yes, combined vaccines against vibriosis and typical and atypical furunculosis have been developed and are effective in Atlantic salmon, and autogenous vaccines can be prepared from local isolates when commercial options are not suitable [2, 31].

What is the significance of mobile genomic islands in A. salmonicida?

Mobile genomic islands, such as GEI-FN1A, contribute to the spread of antibiotic resistance genes among A. salmonicida populations, facilitating the emergence of multidrug-resistant strains [11].

How does co-infection with other pathogens affect furunculosis?

Co-infection with Flavobacterium psychrophilum in rainbow trout results in synergistic increases in mortality and more severe pathophysiological alterations compared to single infections with either pathogen alone [24].

References

[1] Xu N, Li H, Wang X, et al. Aeromonas salmonicida isolated from pigs: Genomic and phenotypic antimicrobial resistance characterization. Open Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/42376538/

[2] Park Y, Han HJ, Kim MS, et al. An effective combined vaccine against vibriosis and typical and atypical furunculosis in Atlantic salmon (Salmo salar). Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42341863/

[3] Nikiforov-Nikishin D, Kochetkov N, Gavrilin K, et al. Dynamics of Pathomorphological and Pathophysiological Alterations in Rainbow Trout (Oncorhynchus mykiss) During Acute Aeromonas salmonicida Infection. Biology (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41154733/

[4] Ren W, Sheng D, Liu Y, et al. Liver transcriptome analysis revealed multiple immune processes and lipid metabolism pathways involved in the defense response of the turbot (Scophthalmus maximus) against Aeromonas salmonicida. Comp Biochem Physiol Part D Genomics Proteomics. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308775/

[5] Mashzhan A, Smekenov I, Bakiyev S, et al. Nanopore genome sequencing of Aeromonas salmonicida strain AB001 from lesions of diseased Acipenser baerii. Front Genet. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42232520/

[6] Souto X, Losada AP, Pardo B, et al. Epibiotic green alga (Ulva spp.) on the skin of turbot (Scophthalmus maximus) with chronic aeromoniasis. Vet Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42018430/

[7] Wang Q, Dong X, Cui M, et al. Isolation and identification of Aeromonas salmonicida of bovine origin and its genome-wide and pathogenicity analysis. Front Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41602755/

[8] Desmecht S, Touzain F, Olivier T, et al. Genomic and virulence insights of Western European Aeromonas salmonicida subsp. salmonicida and development of Galleria mellonella infection assay. J Appl Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40719531/

[9] Park Y, Ko S, Han HJ, et al. Characterization and Vaccine Development of Vibrio anguillarum, Aeromonas salmonicida salmonicida and Aeromonas salmonicida masoucida Isolated from Salmonids in Republic of Korea. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41441704/

[10] Ajmi N, Duman M, Ay H, et al. Genomic and Pangenomic Insights into Aeromonas salmonicida subsp. oncorhynchi subsp. nov. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40559531/

[11] Xie X, Ren Z, Wang R, et al. Mobile Genomic Island GEI-FN1A in Aeromonas salmonicida FN1 Contributes to the Spread of Antibiotic-Resistance Genes. Curr Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40553200/

[12] Fournier KC, Marcoux PÉ, Vincent AT, et al. Strain-Dependent Thermoadaptation in the Fish Pathogen Aeromonas salmonicida subsp. salmonicida. Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41011499/

[13] Paquet MF, Charette SJ. Co-purification of the GroEL chaperone during outer membrane vesicle purification: insights from Aeromonas salmonicida subsp. salmonicida. Microbiology (Reading). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40293439/

[14] Ning Z, Rao W, Shao L, et al. Characterization of high-purity Aeromonas salmonicida extracellular vesicles and their inhibitory activity against Pseudomonas fluorescens biofilm formation. Food Sci Biotechnol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42333110/

[15] Taskesenligil ED, Aygun E, Akbulut S, et al. Biotechnological Application of New Cold-Active Protease From Aeromonas salmonicida subsp. salmonicida EDT1. Biotechnol Appl Biochem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40916475/

[16] Vasquez I, Soto-Davila M, Hossain A, et al. Dual-seq transcriptomics of Aeromonas salmonicida infection in Atlantic salmon (Salmo salar) primary macrophages reveals lysosome and apoptosis impairments. Fish Shellfish Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40262690/ *** Disclaimer:

[17] Maqsood A, Kwabiah RR, Duglas S, et al. Immunomodulatory and cellular effects of Aeromonas salmonicida melanin in Atlantic salmon (Salmo salar). Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42176790/

[18] Tu M, Rao Y, Liu L, et al. Resveratrol blocks the spoilage and virulence phenotypes of Aeromonas salmonicida isolated from sturgeon by inhibiting quorum sensing. Food Res Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41703835/

[19] Hossain A, Gnanagobal H, Cao T, et al. Role of cold shock protein CspA in Aeromonas salmonicida subsp. salmonicida physiology and virulence. Can J Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41774907/

[20] Zhou J, Sun S, Wang W, et al. Transcriptome and resequencing reveal immune-related genes and molecular markers associated with Aeromonas salmonicida resistance in Salmo trutta fario. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41882062/

[21] Liu Y, Guo S, Xue R, et al. Metabolomics Analysis of the Spoilage Characteristics of Pseudomonas fragi and Aeromonas salmonicida Co-Culture in Refrigerated Grass Carp. Foods. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41008199/

[22] Yan J, Guo Z, Xie J. Isolation and Characterization of Aeromonas salmonicida Phage TSW001 and Its Application on Large Yellow Croaker. Foods. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40565690/

[23] Romero Feregrino R, Pacheco Rosas DO, Juárez Castillo A, et al. A Unique Case of Aeromonas salmonicida Peritonitis in a Patient Undergoing Peritoneal Dialysis in Mexico. Cureus. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40959322/

[24] Wang J, Zhao R, Wang Y, et al. Synergistic effects of co-infection with Flavobacterium psychrophilum and Aeromonas salmonicida on mortality, pathophysiology, and immune responses in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40972739/

[25] Sharba S, Sundh H, Santos L, et al. A. salmonicida infection inhibits rainbow trout gill mucin production. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41443520/

[26] Liu M, Wang Q, Zhao Z, et al. Identification and characterization of the septin gene family in rainbow trout (Oncorhynchus mykiss) and their expression profiles in response to Vibrio anguillarum and Aeromonas salmonicida infections. Fish Shellfish Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40623612/

[27] Mikulikova I, Lepkova Z, Bandouchova H, et al. The effect of Lactiplantibacillus plantarum probiotic supplement on rainbow trout challenged with Aeromonas salmonicida. Vet Med (Praha). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146777/

[28] Haghparast A, Rafiee G, Neissi A, et al. Comparative effects of viable and gamma-irradiated Bifidobacterium longum subsp. infantis on immune modulation and resistance to furunculosis in rainbow trout (Oncorhynchus mykiss). BMC Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260355/

[29] De Iorio T, Scatà MC, Apuzzo F, et al. An integrated approach to evaluate the immunomodulatory effect of functional feed on rainbow trout (Oncorhynchus mykiss) during an A. salmonicida outbreak. Fish Physiol Biochem. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40751780/

[30] Zhu X, Wang L, He H, et al. RNA-seq and 16S rRNA analysis revealed the effects of Agaricus bisporus polysaccharides on Aeromonas salmonicida-induced enteritis in crayfish. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41167356/

[31] Zhao D, Wojnarowski K, Cholewińska P, et al. Transcriptomic insights into cultivation-driven virulence in Aeromonas spp.: a new approach to optimizing autogenous vaccines in aquatic veterinary medicine. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41580861/

[32] Kim DH, Joo MS, Jang SR, et al. Impact of Antibiotic Exposure on Growth and Biofilms Formation in Aeromonas salmonicida Subspecies Isolated from Atlantic Salmon (Salmo salar). Microorganisms. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41472065/

[33] Wang X, Zhong L, Purushothaman B, et al. Synergistic effects of gentamicin, levofloxacin, and cefotaxime against Aeromonas salmonicida: In vitro and In vivo evaluation. Bioorg Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41520620/

[34] Santander J, Hossain A, Valderrama K, et al. Transcriptome analysis during thermal-induced endogenous mutagenesis in a strict psychrotrophic Aeromonas salmonicida subp. salmonicida strain. Res Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40659170/

[35] Engert CJ, Medina-Morillo M, Sotil G, et al. Isolation, Characterisation and Virulence of Aeromonas spp. From Peruvian Rainbow Trout: First Description of A. popoffii-Associated Mortality. J Fish Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40439321/